LGALS3 and neoplasm: The PODXLHI-LGALS3LO combination was not found in normal tissue samples but (i) was present most frequently in metastases (53% of samples; Fig. 8G), (ii) was found most frequently in tumors from patients with recurring disease (42.9% patients; compare to 17.7% recurrence when PODXL was not high and LGALS3 was not low; Fig. 8H), (iii) was associated with higher tumor stage (Fig. 8I), and (iv) occurred in patients that had received radiation therapy (Fig. 8J).